Product: Phospho-TAB1 (Ser438) Antibody
Catalog: AF8324
Description: Rabbit polyclonal antibody to Phospho-TAB1 (Ser438)
Application: WB IHC
Reactivity: Human, Mouse, Rat
Prediction: Pig, Horse, Sheep, Rabbit, Dog
Mol.Wt.: 55 kDa; 55kD(Calculated).
Uniprot: Q15750
RRID: AB_2840386

View similar products>>

   Size Price Inventory
 100ul $350 In stock
 200ul $450 In stock

Lead Time: Same day delivery

For pricing and ordering contact:
Local distributors

Product Info

Source:
Rabbit
Application:
WB 1:1000-3000, IHC 1:50-1:200
*The optimal dilutions should be determined by the end user.
*Tips:

WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.

Reactivity:
Human,Mouse,Rat
Prediction:
Pig(100%), Horse(100%), Sheep(100%), Rabbit(100%), Dog(100%)
Clonality:
Polyclonal
Specificity:
Phospho-TAB1 (Ser438) Antibody detects endogenous levels of TAB1 only when phosphorylated at Ser438.
RRID:
AB_2840386
Cite Format: Affinity Biosciences Cat# AF8324, RRID:AB_2840386.
Conjugate:
Unconjugated.
Purification:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
Storage:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
Alias:

Fold/Unfold

2310012M03Rik; 3'-Tab1; MAP3K7IP 1; MAP3K7IP1; MGC57664; Mitogen activated protein kinase kinase kinase 7 interacting protein 1; Mitogen-activated protein kinase kinase kinase 7-interacting protein 1; TAB 1; TAB1; TAB1_HUMAN; TAK1 binding protein 1; TAK1-binding protein 1; TGF beta activated kinase 1 binding protein 1; TGF-beta activated kinase 1/MAP3K7 binding protein 1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1; TGF-beta-activated kinase 1-binding protein 1; Transforming growth factor beta activated kinase binding protein 1;

Immunogens

Immunogen:
Uniprot:
Gene(ID):
Expression:
Q15750 TAB1_HUMAN:

Ubiquitous.

Sequence:
MAAQRRSLLQSEQQPSWTDDLPLCHLSGVGSASNRSYSADGKGTESHPPEDSWLKFRSENNCFLYGVFNGYDGNRVTNFVAQRLSAELLLGQLNAEHAEADVRRVLLQAFDVVERSFLESIDDALAEKASLQSQLPEGVPQHQLPPQYQKILERLKTLEREISGGAMAVVAVLLNNKLYVANVGTNRALLCKSTVDGLQVTQLNVDHTTENEDELFRLSQLGLDAGKIKQVGIICGQESTRRIGDYKVKYGYTDIDLLSAAKSKPIIAEPEIHGAQPLDGVTGFLVLMSEGLYKALEAAHGPGQANQEIAAMIDTEFAKQTSLDAVAQAVVDRVKRIHSDTFASGGERARFCPRHEDMTLLVRNFGYPLGEMSQPTPSPAPAAGGRVYPVSVPYSSAQSTSKTSVTLSLVMPSQGQMVNGAHSASTLDEATPTLTNQSPTLTLQSTNTHTQSSSSSSDGGLFRSRPAHSLPPGEDGRVEPYVDFAEFYRLWSVDHGEQSVVTAP

Predictions

Predictions:

Score>80(red) has high confidence and is suggested to be used for WB detection. *The prediction model is mainly based on the alignment of immunogen sequences, the results are for reference only, not as the basis of quality assurance.

Species
Results
Score
Pig
100
Horse
100
Sheep
100
Dog
100
Rabbit
100
Zebrafish
67
Bovine
0
Xenopus
0
Chicken
0
Model Confidence:
High(score>80) Medium(80>score>50) Low(score<50) No confidence

PTMs - Q15750 As Substrate

Site PTM Type Enzyme
S7 Phosphorylation
S11 Phosphorylation
S16 Phosphorylation
K42 Ubiquitination
K150 Ubiquitination
Y179 Phosphorylation
T185 Phosphorylation
K192 Ubiquitination
K227 Ubiquitination
K229 Ubiquitination
K249 Ubiquitination
K262 Ubiquitination
K264 Ubiquitination
S339 Phosphorylation
T376 Phosphorylation
S378 Phosphorylation
S395 O-Glycosylation
S423 Phosphorylation Q16539 (MAPK14)
T431 Phosphorylation Q16539 (MAPK14)
S438 Phosphorylation Q16539 (MAPK14)
T442 Phosphorylation
S452 Phosphorylation O43318 (MAP3K7) , Q16539 (MAPK14)
S453 Phosphorylation O43318 (MAP3K7) , Q16539 (MAPK14)
S456 Phosphorylation Q16539 (MAPK14) , O43318 (MAP3K7)
S457 Phosphorylation Q16539 (MAPK14) , O43318 (MAP3K7)
S469 Phosphorylation
Y481 Phosphorylation
Y488 Phosphorylation
S492 Phosphorylation

Research Backgrounds

Function:

May be an important signaling intermediate between TGFB receptors and MAP3K7/TAK1. May play an important role in mammalian embryogenesis.

PTMs:

Monoubiquitinated. Deubiquitinated by Y.enterocolitica YopP.

Tissue Specificity:

Ubiquitous.

Subunit Structure:

Interacts with XIAP and BIRC7. Interacts with TRAF6 and MAP3K7; during IL-1 signaling. Identified in the TRIKA2 complex composed of MAP3K7, TAB1 and TAB2.

Research Fields

· Environmental Information Processing > Signal transduction > MAPK signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > TNF signaling pathway.   (View pathway)

· Human Diseases > Infectious diseases: Parasitic > Leishmaniasis.

· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.

· Organismal Systems > Development > Osteoclast differentiation.   (View pathway)

· Organismal Systems > Immune system > Toll-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > NOD-like receptor signaling pathway.   (View pathway)

References

1). GFAT1-linked TAB1 glutamylation sustains p38 MAPK activation and promotes lung cancer cell survival under glucose starvation. Cell discovery, 2022 (PubMed: 35945223) [IF=33.5]

Application: WB    Species: Human    Sample: A549 cells

Fig. 2 TAB1 interacts with GFAT1 in a Ser438 phosphorylation-dependent manner. a TAB1 could interact with GFAT1. A549 cells with stable expression of Flag-GFAT1 were cultured for 8 h under glucose deprivation. Immunoprecipitation and immunoblotting analyses were performed using the indicated antibodies. Silver staining analysis of the immunoprecipitates was performed. b TAB1–GFAT1 interaction was phosphorylation-dependent. A549 cells were cultured for 8 h under glucose deprivation. Immunoprecipitation and immunoblotting analyses were performed using the indicated antibodies. c TAB1 phosphorylation mediated TAB1–GFAT1 interaction. The indicated purified GST-GFAT1 or His-TAB1 protein was mixed with cell lysates from A549 cells cultured for 8 h under glucose deprivation. Pull-down and immunoblotting analyses were performed using the indicated antibodies. d JNK/p38 mediated TAB1–GFAT1 interaction. A549 cells were pretreated with Compound C (10 μM), SP600125 (20 μM), and SB203580 (10 μM) for 1 h before being cultured for 8 h under glucose deprivation. Immunoprecipitation and immunoblotting analyses were performed using the indicated antibodies. e Ser438 of TAB1 is evolutionarily conserved in the indicated species (upper panel). TAB1 Ser438 phosphorylation mediated TAB1–GFAT1 interaction. A549 cells with transient expression of WT TAB1, TAB1-S423A, TAB1-T431A or TAB1-S438A were cultured for 8 h under glucose deprivation. Immunoprecipitation and immunoblotting analyses were performed using the indicated antibodies (lower panel). f His-TAB1 Ser438 could be phosphorylated by p38α or JNK1. Purified His-TAB1 proteins were subjected to in vitro kinase assay. g, h In vitro binding of His-TAB1 and GST-GFAT1. Purified His-TAB1 WT and His-TAB1-S438A protein with phosphorylation by p38α (g) or JNK1 (h) was mixed with purified GST-GFAT1. Pull-down and immunoblotting analyses were performed using the indicated antibodies. i Expression of rTAB1-S438A inhibited p38 activation at late time points. A549 cells with depleted TAB1 and reconstituted expression of WT rTAB1 or rTAB1-S438A were cultured for indicated time under glucose deprivation. Immunoblotting analyses were performed using the indicated antibodies. In i, the values are presented as means ± SEM, n = 3; *P 

Restrictive clause

 

Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.

For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.